Herpes simplex virus 1 (HSV-1) encephalitis (HSE) is the most common sporadic viral encephalitis in Western countries. Forebrain HSE (which develops via olfactory neurons) in otherwise healthy children can result from inborn errors of the TLR3 pathway (mutations in TLR3, UNC93B1, TRIF, TRAF3, TBK1, and IRF3), whereas brainstem HSE (via trigeminal (TG) neurons) can result from inborn errors of RNA lariat metabolism (DBR1). Children with a broader defect of impaired production of (NEMO) or response to all IFNs (STAT1) are prone to HSE and other infections. We analyzed the cellular basis of HSE by deriving peripheral and central nervous system (PNS and CNS) cells from induced pluripotent stem cells (iPSC) (NIH R01NS072381). TLR3-deficient forebrain cortical neurons and oligodendrocyte precursors have impaired anti-HSV-1 cell-intrinsic immunity, unlike astrocytes and neural stem cells; microglial cells were not tested. Moreover, iPSC-derived TG neurons do not rely on TLR3 to control HSV-1; olfactory neurons were not tested. Finally, TLR3 controls both basal IFN levels and early steps of anti-HSV-1 immunity in cortical neurons. Childhood HSE results thus from inborn errors of non-hematopoietic, CNS-specific, cell-intrinsic immunity, affecting cortical neurons and oligodendrocytes in particular. We have since identified new forebrain HSE-causing genes that are connected to the TLR3-IFN circuit (MEX3B, IFNAR1), the TLR3-necroptosis pathway (RIPK1, RIPK3), and of unknown function (SNORA31, TMEFF1). In this renewal application, we hypothesize that genetic etiologies of forebrain HSE impair intrinsic immunity in cortical but not olfactory neurons, and in oligodendrocytes and probably microglial cells, and DBR1 deficiency impairs intrinsic immunity in brainstem and/or TG neurons and probably microglial cells. First, we will assess the responses of iPSC-derived olfactory and cortical neurons, and other CNS cells, from controls and patients mutated in new forebrain HSE-causing genes, to TLR3, IFN-?/? or IFN-?, and HSV-1 stimulation. Second, we will study RNA lariat accumulation, immunity to HSV-1 infection, and responses to IFN-?/? or IFN- ?, in control and DBR1-deficient iPSC-differentiated TG and brainstem neurons. Third, the role of microglial cells in forebrain vs brainstem HSE will be assessed by studying the responses to TLR3 agonists, IFN-?/?, IFN-? and HSV-1, in isolation and in neuronal co-culture. Patient and isogenic iPSC lines in which the mutation is corrected or introduced by gene editing will be used. Cell-intrinsic immunity to HSV-1 and its molecular basis will be analyzed. Exciting preliminary data have been obtained, including (1) novel genetic etiologies of HSE, (2) novel mechanisms by which TLR3 controls HSV-1 in cortical neurons, and (3) novel protocols to differentiate brainstem neurons and microglial cells. The expand of this human iPSC-based study of HSE will enable us to dissect in greater breadth and depth its molecular and cellular basis in children with inborn errors of CNS-intrinsic immunity to HSV-1.
HSE is a life-threatening viral infection of the CNS. In some children, forebrain HSE is caused by inborn errors of TLR3-, IFN-a/b or -l-mediated CNS-intrinsic immunity, whereas in others, brainstem HSE is caused by inborn errors of DBR1-dependent RNA lariat metabolism, which probably disrupts CNS-intrinsic immunity by TLR3- and IFN-independent mechanisms. We aim to study the CNS-, tissue-, and cell-intrinsic basis of forebrain and brainstem HSE in two complementary ways: (i) we will analyze TLR3, IFN responses and HSV-1 infection in iPSC-derived olfactory and cortical neurons, and other CNS cells including microglial cells, from patients carrying known and novel genetic etiologies of forebrain HSE, (ii) we will analyze lariat accumulation and HSV-1 infection in TG and brainstem neurons, and other CNS cells including microglial cells, derived from DBR1-deficient patient iPSCs. These studies should enable us to analyze in greater depth and breadth the cellular basis of human CNS- intrinsic immunity to HSV-1 and the pathogenesis of HSE.
| Casanova, Jean-Laurent; Abel, Laurent (2018) Human genetics of infectious diseases: Unique insights into immunological redundancy. Semin Immunol 36:1-12 |
| Zimmer, Bastian; Ewaleifoh, Osefame; Harschnitz, Oliver et al. (2018) Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection. Proc Natl Acad Sci U S A 115:E8775-E8782 |
| Sologuren, Ithaisa; Martínez-Saavedra, María Teresa; Solé-Violán, Jordi et al. (2018) Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency. J Clin Immunol : |
| Bucciol, Giorgia; Moens, Leen; Bosch, Barbara et al. (2018) Lessons learned from the study of human inborn errors of innate immunity. J Allergy Clin Immunol : |
| Zhang, Shen-Ying; Clark, Nathaniel E; Freije, Catherine A et al. (2018) Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection. Cell 172:952-965.e18 |
| Cornacchia, Daniela; Studer, Lorenz (2017) Back and forth in time: Directing age in iPSC-derived lineages. Brain Res 1656:14-26 |
| Soliman, M A; Aboharb, F; Zeltner, N et al. (2017) Pluripotent stem cells in neuropsychiatric disorders. Mol Psychiatry 22:1241-1249 |
| Belkaya, Serkan; Kontorovich, Amy R; Byun, Minji et al. (2017) Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. J Am Coll Cardiol 69:1653-1665 |
| Qi, Yuchen; Zhang, Xin-Jun; Renier, Nicolas et al. (2017) Combined small-molecule inhibition accelerates the derivation of functional cortical neurons from human pluripotent stem cells. Nat Biotechnol 35:154-163 |
| Tchieu, Jason; Zimmer, Bastian; Fattahi, Faranak et al. (2017) A Modular Platform for Differentiation of Human PSCs into All Major Ectodermal Lineages. Cell Stem Cell 21:399-410.e7 |
Showing the most recent 10 out of 24 publications
